HealthEx, a San Francisco, CA-based provider of a global consumer preference and consent platform for healthcare to unlock data access, raised $14M in Seed and Series A funding.
The round was led by General Catalyst, with participation from Electric Capital.
The company intends to use the funds to accelerate the expansion of its AI-powered platform, scale development to simplify integrating the patient voice across all healthcare activities, while simultaneously automating the manual burden of security and compliance processes needed in the increasingly complex landscape of health data access.
founded by Priyanka Agarwal, MD, MBA, who was previously at UCSF and MyoKardia, acquired by Bristol Myers Squibb, and Anand Raghavan, who was previously part of the founding team and VP of Engineering at BlueJeans, acquired by Verizon, HealthEx provides an AI-driven preference and consent platform that simplifies patient experience, automates security and compliance for healthcare organizations. The solution enables healthcare organizations to create, collect, and enforce patient consent and preferences, and allow health systems to fulfill their roles as trusted stewards of patient data. Healthcare organizations can enhance the patient experience, boost operational efficiency, increase compliance, and unlock new data licensing opportunities.
Built in collaboration with leading health systems, the HealthEx solution will help manage massive amounts of unstructured content in lengthy consents, legal contracts, and other policy documents governing data access and transform this content into automated, enforceable workflows.
FinSMEs
22/10/2024